Utilization of bronchodilators in ventilated patients without obstructive airways disease

Respiratory Care

Volumn 52, Issue 2, 2007, Pages 154-158

  Chang, Lydia H ^a   Honiden, Shyoko ^b   Haithcock, John A ^c   Das, Aneesa M ^d   Short, Kathy A ^c   Nierman, David M ^b   Carson, Shannon S ^d  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c Department of Respiratory Therapy ^*

^d UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

Albuterol; Inhaled bronchodilators; Intubation; Ipratropium bromide; Mechanical ventilation; Obstructive lung disease

Indexed keywords

BRONCHODILATING AGENT; IPRATROPIUM BROMIDE; SALBUTAMOL;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; DRUG COST; DRUG UTILIZATION; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOKALEMIA; HYPOXEMIA; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRESCRIPTION; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; TRACHEOSTOMY; VENTILATOR ASSOCIATED PNEUMONIA; ECONOMICS; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; TREATMENT OUTCOME; UNNECESSARY PROCEDURE;

ADMINISTRATION, INHALATION; ADULT; AGED; ALBUTEROL; BRONCHODILATOR AGENTS; COHORT STUDIES; FEMALE; HUMANS; INTENSIVE CARE UNITS; IPRATROPIUM; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; TREATMENT OUTCOME; UNNECESSARY PROCEDURES;

EID: 33947520291     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Dhand R, Tobin MJ. Inhaled bronchodilator therapy in mechanically ventilated patients. Am J Respir Crit Care Med 1997;156(1):3-10.
2. Bennett WD. Effect of beta-adrenergic agonists on mucociliary clearance. J Allergy Clin Immunol 2002;110(6 Suppl):S291-S297.
3. Wright PE, Carmichael LC, Bernard GR. Effect of bronchodilators on lung mechanics in the acute respiratory distress syndrome (ARDS). Chest 1994;106(5):1517-1523.
4. Pesenti A, Pelosi P, Rossi N, Aprigliano M, Brazzi L, Fumagalli R. Respiratory mechanics and bronchodilator responsiveness in patients with the adult respiratory distress syndrome. Crit Care Med 1993;21(1):78-83.
5. Morina P, Herrera M, Venegas J, Mora D, Rodriguez M, Pino E. Effects of nebulized salbutamol on respiratory mechanics in adult respiratory distress syndrome. Intensive Care Med 1997;23(1):58-64.
6. Mancebo J, Amaro P, Lorino H, Lemaire F, Harf A, Brochard L. Effects of albuterol inhalation on the work of breathing during weaning from mechanical ventilation. Am Rev Respir Dis 1991;144(1):95-100.
7. Mutlu GM, Sznajder JI. Beta2-agonists for treatment of pulmonary edema: ready for clinical studies? Crit Care Med 2004;32(7):1607-1608.
8. McAuley DF, Frank JA, Fang X, Matthay MA. Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Crit Care Med 2004;32(7):1470-1476.
9. Lasnier JM, Wangensteen OD, Schmitz LS, Gross CR, Ingbar DH. Terbutaline stimulates alveolar fluid resorption in hyperoxic lung injury. J Appl Physiol 1996;81(4):1723-1729.
10. Frank JA, Wang Y, Osorio O, Matthay MA. Beta-adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats. J Appl Physiol 2000;89(4):1255-1265.
11. Sakuma T, Folkesson HG, Suzuki S, Okaniwa G, Fujimura S, Matthay MA. Beta-adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs. Am J Respir Crit Care Med 1997;155(2):506-512.
12. Ahrens RC, Smith GD. Albuterol: an adrenergic agent for use in the treatment of asthma pharmacology, pharmacokinetics and clinical use. Pharmacotherapy 1984;4(3):105-121.
13. Abramson MJ, Walters J, Walters EH. Adverse effects of beta-agonists: are they clinically relevant? Am J Respir Med 2003;2(4):287-297.
14. Hung CH, Chu DM, Wang CL, Yang KD. Hypokalemia and salbutamol therapy in asthma. Pediatr Pulmonol 1999;27(1):27-31.
15. Pingleton SK, Fagon JY, Leeper KV Jr. Patient selection for clinical investigation of ventilator-associated pneumonia: criteria for evaluating diagnostic techniques. Chest 1992;102(5 Suppl 1):553S-556S.
16. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3 Pt 1):818-824.
17. Rello J, Paiva JA, Baraibar J, Barcenilla F, Bodi M, Castander D, et al. International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia. Chest 2001;120(3):955-970.
18. Seneff MG, Zimmerman JE, Knaus WA, Wagner DP, Draper EA. Predicting the duration of mechanical ventilation: the importance of disease and patient characteristics. Chest 1996;110(2):469-479.
19. Konrad F, Schreiber T, Brecht-Kraus D, Georgieff M. Mucociliary transport in ICU patients. Chest 1994;105(1):237-241.
20. Konrad F, Schiener R, Marx T, Georgieff M. Ultrastructure and mucociliary transport of bronchial respiratory epithelium in intubated patients. Intensive Care Med 1995;21(6):482-489.
21. Dolovich M, Rushbrook J, Churchill E, Mazza M, Powles AC. Effect of continuous lateral rotational therapy on lung mucus transport in mechanically ventilated patients. J Crit Care 1998;13(3):119-125.
22. Wright PE, Bernard GR. The role of airflow resistance in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1989;139(5):1169- 1174.
23. Perkins GD, McAuley DF, Thickett DR, Gao F. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006;173(3):281-287.